Schedule 13G ownership disclosure

VIRIOS THERAPEUTICS INC

Security class unavailable · CUSIP: 92829J104

Event date: 2023-06-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,327,051
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001654954-23-007954
Form type
SC 13G/A
Filer
Corday Brian David
CIK
CIK 1322787
Filed
Jun 13, 2023
Reporting period
Jun 13, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub